Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A role for FGF2 in visceral adiposity-associated mammary epithelial transformation.

Benham V, Chakraborty D, Bullard B, Bernard JJ.

Adipocyte. 2018;7(2):113-120. doi: 10.1080/21623945.2018.1445889. Epub 2018 Mar 21.

PMID:
29561195
2.

Why does a high-fat diet increase cancer risk?

Benham V, Bernard JJ.

Future Oncol. 2018 Mar;14(7):583-588. doi: 10.2217/fon-2017-0610. Epub 2018 Feb 7. No abstract available.

PMID:
29411646
3.

A BET Bromodomain Inhibitor Suppresses Adiposity-Associated Malignant Transformation.

Chakraborty D, Benham V, Jdanov V, Bullard B, Leal AS, Liby KT, Bernard JJ.

Cancer Prev Res (Phila). 2018 Mar;11(3):129-142. doi: 10.1158/1940-6207.CAPR-17-0262. Epub 2017 Dec 15.

PMID:
29246955
4.

Elucidating the role of adipose tissue secreted factors in malignant transformation.

Chakraborty D, Benham V, Bernard JJ.

Adipocyte. 2018 Jan 2;7(1):45-48. doi: 10.1080/21623945.2017.1388971. Epub 2017 Nov 2.

PMID:
29095087
5.

Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer.

Chakraborty D, Benham V, Bullard B, Kearney T, Hsia HC, Gibbon D, Demireva EY, Lunt SY, Bernard JJ.

Oncogene. 2017 Nov 30;36(48):6668-6679. doi: 10.1038/onc.2017.278. Epub 2017 Aug 7.

6.

First experimental demonstration of self-synchronous phase locking of an optical array.

Shay TM, Benham V, Baker JT, Ward B, Sanchez AD, Culpepper MA, Pilkington D, Spring J, Nelson DJ, Lu CA.

Opt Express. 2006 Dec 11;14(25):12015-21.

PMID:
19529628

Supplemental Content

Loading ...
Support Center